16 Oct 2024
07:00 CEST |
EUROAPI SA |
Olivier Falut est nommé Directeur financier d’EUROAPI
|
20103015 Pharmaceuticals |
Other subject |
16 Oct 2024
07:00 CEST |
EUROAPI SA |
Olivier Falut appointed EUROAPI’s Chief Financial Officer
|
20103015 Pharmaceuticals |
Other subject |
15 Oct 2024
17:45 CEST |
EUROAPI SA |
EUROAPI clôt le financement de son plan FOCUS-27
|
20103015 Pharmaceuticals |
Other subject |
15 Oct 2024
17:45 CEST |
EUROAPI SA |
EUROAPI closes the financing of its FOCUS-27 plan
|
20103015 Pharmaceuticals |
Other subject |
10 Oct 2024
20:38 CEST |
EUROAPI SA |
EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution
|
20103015 Pharmaceuticals |
Other subject |
10 Oct 2024
20:38 CEST |
EUROAPI SA |
EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution
|
20103015 Pharmaceuticals |
Other subject |
05 Aug 2024
08:00 CEST |
EUROAPI SA |
EUROAPI - Availability of 2024 Half-Year Financial Report
|
20103015 Pharmaceuticals |
Income |
05 Aug 2024
08:00 CEST |
EUROAPI SA |
EUROAPI - Mise à disposition du Rapport financier semestriel 2024
|
20103015 Pharmaceuticals |
Income |
30 Jul 2024
17:45 CEST |
EUROAPI SA |
H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap
|
20103015 Pharmaceuticals |
Other subject |
30 Jul 2024
17:45 CEST |
EUROAPI SA |
RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne voie avec une exécution dans les délais de la feuille de route opérationnelle
|
20103015 Pharmaceuticals |
Other subject |
26 Jun 2024
17:40 CEST |
EUROAPI SA |
EUROAPI is moving ahead with its FOCUS-27 plan, setting the foundations for future profitable growth1
|
20103015 Pharmaceuticals |
Other subject |
26 Jun 2024
17:40 CEST |
EUROAPI SA |
EUROAPI poursuit sa transformation grâce au plan FOCUS-27 et pose les bases d’une future croissance rentable1
|
20103015 Pharmaceuticals |
Other subject |
18 Jun 2024
07:00 CEST |
EUROAPI SA |
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
|
20103015 Pharmaceuticals |
Other subject |
18 Jun 2024
07:00 CEST |
EUROAPI SA |
EUROAPI et Priothera signent un accord de CDMO pour un projet en oncologie
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2024
17:53 CEST |
EUROAPI SA |
Information marché Financement du projet de transformation FOCUS-27
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2024
17:53 CEST |
EUROAPI SA |
Market update : FOCUS-27 transformation project financing
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2024
07:00 CEST |
EUROAPI SA |
EUROAPI franchit une étape majeure du PIIEC Santé avec la notification officielle de la Commission européenne
|
20103015 Pharmaceuticals |
Other subject |
06 Jun 2024
07:00 CEST |
EUROAPI SA |
EUROAPI reaches major Health IPCEI milestone with official notification from European Commission
|
20103015 Pharmaceuticals |
Other subject |
23 May 2024
07:00 CEST |
EUROAPI SA |
EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros
|
20103015 Pharmaceuticals |
Other subject |
23 May 2024
07:00 CEST |
EUROAPI SA |
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
|
20103015 Pharmaceuticals |
Other subject |
22 May 2024
17:45 CEST |
EUROAPI SA |
Combined General Meeting of May 22, 2024
|
20103015 Pharmaceuticals |
Other subject |
22 May 2024
17:45 CEST |
EUROAPI SA |
Assemblée Générale Mixte du 22 mai 2024
|
20103015 Pharmaceuticals |
Other subject |
13 May 2024
18:00 CEST |
EUROAPI SA |
Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer
|
20103015 Pharmaceuticals |
Other subject |
13 May 2024
18:00 CEST |
EUROAPI SA |
Evelyne Nguyen est nommée Directrice financière d’EUROAPI
|
20103015 Pharmaceuticals |
Other subject |
30 Apr 2024
07:00 CEST |
EUROAPI SA |
Combined General Meeting of May 22, 2024 - Availability of preparatory documents
|
20103015 Pharmaceuticals |
Other subject |
30 Apr 2024
07:00 CEST |
EUROAPI SA |
Assemblée Générale mixte du 22 mai 2024 - Modalités de mise à disposition ou de consultation des documents préparatoires
|
20103015 Pharmaceuticals |
Other subject |
09 Apr 2024
18:18 CEST |
EUROAPI SA |
EUROAPI streamlines its Executive Committee to improve focus and efficiency
|
20103015 Pharmaceuticals |
Other subject |
09 Apr 2024
18:18 CEST |
EUROAPI SA |
EUROAPI resserre son Comité exécutif afin de se recentrer et de gagner en efficacité
|
20103015 Pharmaceuticals |
Other subject |
05 Apr 2024
18:20 CEST |
EUROAPI SA |
Availability of the 2023 Universal Registration Document, including the Annual Financial Report
|
20103015 Pharmaceuticals |
Other subject |
05 Apr 2024
18:20 CEST |
EUROAPI SA |
Mise à disposition du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2024
07:00 CET |
EUROAPI SA |
Document d’Enregistrement Universel 2023
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2024
07:00 CET |
EUROAPI SA |
2023 Universal Registration Document
|
20103015 Pharmaceuticals |
Other subject |
14 Mar 2024
18:55 CET |
EUROAPI SA |
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
|
20103015 Pharmaceuticals |
Other subject |
14 Mar 2024
18:55 CET |
EUROAPI SA |
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
|
20103015 Pharmaceuticals |
Other subject |
28 Feb 2024
19:16 CET |
EUROAPI SA |
Résultats annuels 2023
|
20103015 Pharmaceuticals |
Other subject |
28 Feb 2024
19:16 CET |
EUROAPI SA |
Full-year 2023 results
|
20103015 Pharmaceuticals |
Other subject |
25 Jan 2024
07:00 CET |
EUROAPI SA |
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO)
|
20103015 Pharmaceuticals |
Other subject |
25 Jan 2024
07:00 CET |
EUROAPI SA |
EUROAPI enrichit ses compétences en CDMO grâce à une collaboration essentielle avec SpiroChem, une Contract Research Organization (CRO) de premier plan
|
20103015 Pharmaceuticals |
Other subject |
04 Jan 2024
17:45 CET |
EUROAPI SA |
EUROAPI renforce son Comité Exécutif en nommant Ludwig de Mot Directeur Général Adjoint, en charge de la transformation de l’entreprise
|
20103015 Pharmaceuticals |
Other subject |
04 Jan 2024
17:45 CET |
EUROAPI SA |
EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer
|
20103015 Pharmaceuticals |
Other subject |
28 Nov 2023
08:00 CET |
EUROAPI SA |
EUROAPI Appoints New Executive Committee Members
|
20103015 Pharmaceuticals |
Other subject |
28 Nov 2023
08:00 CET |
EUROAPI SA |
EUROAPI nomme de nouveaux membres au Comité Exécutif
|
20103015 Pharmaceuticals |
Other subject |
21 Nov 2023
17:45 CET |
EUROAPI SA |
CDMO : EUROAPI finalise l’acquisition de Biano
|
20103015 Pharmaceuticals |
Other subject |
21 Nov 2023
17:45 CET |
EUROAPI SA |
CDMO: EUROAPI Completes Acquisition of Biano
|
20103015 Pharmaceuticals |
Other subject |
30 Oct 2023
18:38 CET |
EUROAPI SA |
EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer
|
20103015 Pharmaceuticals |
Other subject |
30 Oct 2023
18:38 CET |
EUROAPI SA |
EUROAPI : Information relative aux conditions financières du départ du Directeur Général et de la nomination de la Présidente du Conseil d’Administration comme Directrice Générale par intérim
|
20103015 Pharmaceuticals |
Other subject |
25 Oct 2023
18:15 CEST |
EUROAPI SA |
Nouvelle gouvernance chez EUROAPI
|
20103015 Pharmaceuticals |
Other subject |
25 Oct 2023
18:15 CEST |
EUROAPI SA |
EUROAPI Announces New Governance
|
20103015 Pharmaceuticals |
Other subject |
24 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI Increases the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux
|
20103015 Pharmaceuticals |
Other subject |
24 Oct 2023
17:45 CEST |
EUROAPI SA |
EUROAPI : Augmentation des moyens affectés au contrat de liquidité conclu avec Kepler Cheuvreux
|
20103015 Pharmaceuticals |
Other subject |